Interactive discussion: what are the implications of SGLT2 inhibition for CV risk reduction in a multi-risk patient population?

28 August 2016 (16:00 - 16:15)
Organised by:
Congress Presentation Part of: SGLT2 inhibition in the management of CV risk & T2DM: ask the experts Diabetes management ESC Premium Access ESC Congress 2016